Precision Diagnostics DxTerity focuses on RNA-based immune profiling for autoimmune diseases, presenting opportunities to partner with clinics, pharma, and research institutions seeking precision medicine solutions for conditions like lupus.

Strategic Partnerships Recent collaborations with Lupus Research Alliance and other organizations indicate a receptiveness to joint studies and sponsored research, suggesting potential for co-branded studies, data collaborations, and targeted funding programs.

New Product Adoption Launch of the IFN-1 Test and at-home/home-based testing initiatives show a trajectory toward scalable diagnostics, presenting cross-sell opportunities for related autoimmune panels and digital health integrations.

SMB and Enterprise Reach With prior distribution via Amazon for at-home tests and a B2B screening service, there is a channel-ready path to offer employer health programs, occupational health partnerships, and direct-to-employer services.

Growth Readiness Revenue in the low-to-mid single digits with a lean team suggests a need for scalable sales enablement, channel partnerships, and pilot programs to accelerate market penetration in autoimmune diagnostics.